Arimoclomol
id:
arimoclomol-183-6686091
title:
Arimoclomol
text:
Arimoclomol is an experimental drug developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. In 2011 the worldwide rights to arimoclomol were bought by Danish biotech company Orphazyme ApS. The European Medicines Agency (EMA) and U.S. Food & Drug Administration (FDA) granted orphan drug designation to arimoclomol as a potential treatment for Niemann-Pick type C in 2014 and 2015 respectively.
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental drug
original url:
https://en.wikipedia.org/wiki/Arimoclomol
date created:
2006-04-18T21:54:58Z
date modified:
2024-09-07T08:47:30Z
main entity:
{"identifier":"Q4790694","url":"https://www.wikidata.org/entity/Q4790694"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/ba/Arimoclomol.svg","width":1639,"height":614}
fields total:
13
integrity:
16